Clinical trial
Use of the Cannabinoid Nabilone for the Promotion of Sleep in Chronic…
NCT00384410 · University Health Network, Toronto, Other · Unknown status
Key facts
| NCT number | NCT00384410 |
|---|---|
| Title | Use of the Cannabinoid Nabilone for the Promotion of Sleep in Chronic, Non-Malignant Pain Patients |
| Official title | Use of the Cannabinoid Nabilone for the Promotion of Sleep in Chronic, Non-Malignant Pain Patients: A Placebo-Controlled, Randomized, Crossover Insomnia Pilot Study |
| Lead sponsor | University Health Network, Toronto, Other |
| Collaborators | Bausch Health Americas, Inc. Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pain, Insomnia |
| Intervention type | Drug |
| Interventions | Nabilone |
| Enrollment | 16 |
| Start date | Dec 1, 2005 |
| First posted | Oct 6, 2006 |
| Last update posted | Oct 6, 2006 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: